Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma
Clinical trial NCT00389506 · WITHDRAWN
Trial details
- NCT number
- NCT00389506
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.